We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

新型快速检验报告抗生素耐受只需两小时

By LabMedica International staff writers
Posted on 18 Apr 2018
Print article
芯片实验室系统与拉曼谱配合使用,鉴定抗生素耐受性(图片蒙莱布尼兹光子技术研究所惠赐)。
芯片实验室系统与拉曼谱配合使用,鉴定抗生素耐受性(图片蒙莱布尼兹光子技术研究所惠赐)。
耐药细菌正在全世界蔓延,必须快速进行抗生素敏感性试验,确定最小抑菌浓度(MIC),以便及时选择恰当的抗生素疗法。
 
抗生物的使用日渐泛滥,且经常不必要,导致病原体产生耐药性,本应很容易治愈的感染也许会致命。一种新型的快速检验将得知哪些现有的抗生素仍有效,更快的诊断可实现个性化疗法,挽救生命。
 
德国耶拿大学医院的科学家及其同事开发了一种简单快速的拉曼谱检查,以鉴定对抗生素的敏感性,短短两小时就可完成总体分析,确定MIC,比今天诊断所用的成熟的表现型方法节省大量时间。
 
样品制备也比现行的成熟检验更快、更容易。介电泳芯片可自动收集微米见方的细菌,直接用细菌悬浮液测得高质量拉曼谱。用13份大肠杆菌临床分离物确证新型拉曼谱MIC检验,这些分离物来自血流感染患者,表现出对环丙沙星不同程度的耐受性。
 
微拉曼谱能够检测与环丙沙星相互作用90分钟后大肠杆菌的变化。进行主分量分析并简单计算1458和1485 cm–1处拉曼标志带的比率,结果显示出清晰的浓度依赖效应。新型拉曼谱方法确定的MIC值与微量肉汤稀释法、Vitek-2和法国生物梅里埃公司的E-test等参考方法得到的MIC值吻合得很好,可用于区分是敏感、中等还是耐受。
 
该研究的论文发表于2018年2月号的《分析化学》(Analytical Chemistry)杂志。资深作者、物理化学教授Ute Neugebauer博士说:“我们联用基于光的分析方法与微流控样本处理。我们的芯片实验室系统是一个微型实验室,有了它,我们就能明确鉴定菌株及其耐药性,需时不到三小时。”
 
Related Links:

耶拿大学医院>>> www.uni-jena.de

生物梅里埃>>> www.biomerieux.com


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more